Trials / Completed
CompletedNCT05209685
Blood Flow Restriction on Functional Mobility in Pre-frail Older Adults
Effect of Blood Flow Restriction Resistance Exercise on Functional Mobility in Pre-Frail Older Adults
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 54 (actual)
- Sponsor
- National Cheng Kung University · Academic / Other
- Sex
- All
- Age
- 65 Years – 95 Years
- Healthy volunteers
- Not accepted
Summary
This study investigates the effect of blood flow restriction with resistance exercise on functional mobility in pre-frail older adults. It is hypothesized that receiving resistance exercise with blood flow restriction will exhibit better improvement on functional mobility than only receiving resistance exercise in pre-frail older adults.
Detailed description
Participants aged over 65 years old with less than two items positive of Fried frailty phenotype assessment result will be recruited. The participants will be randomly assigned to two training groups, blood flow restriction resistance exercise and traditional resistance exercise. Both groups will receive the training 30 minutes/session, two sessions/week for six weeks. Muscle strength of the lower extremities and functional mobility tests will be used to assess outcomes at pre-training, 3-week after training, post-training, and one-month and two-month follow-up.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Resistance exercise on the lower extremities | Resistance exercise mainly on the lower extremities will be executed by carrying weight according to each participant's tolerance while performing certain movements, such as side step-up, sit-to-stand, and tip-toe-standing. |
| OTHER | Resistance exercise on the lower extremities with blood flow restriction | Blood flow restriction on the thigh of the dominant leg will be used in combination with resistance exercise. |
Timeline
- Start date
- 2020-08-17
- Primary completion
- 2022-10-31
- Completion
- 2022-12-31
- First posted
- 2022-01-26
- Last updated
- 2023-11-27
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT05209685. Inclusion in this directory is not an endorsement.